Boston Scientific Corp
NYSE:BSX
Boston Scientific Corp
Non-Reccuring Items
Boston Scientific Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Boston Scientific Corp
NYSE:BSX
|
Non-Reccuring Items
-$402m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
11%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Non-Reccuring Items
-$480m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-36%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Non-Reccuring Items
-$46.4m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Non-Reccuring Items
-$1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Non-Reccuring Items
-$350m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
Glance View
In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.
See Also
What is Boston Scientific Corp's Non-Reccuring Items?
Non-Reccuring Items
-402m
USD
Based on the financial report for Dec 31, 2024, Boston Scientific Corp's Non-Reccuring Items amounts to -402m USD.
What is Boston Scientific Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
11%
The average annual Non-Reccuring Items growth rates for Boston Scientific Corp have been 24% over the past three years , -6% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet